Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Surbhi Jain

Novo, Pfizer Are Battling To Buy The Future Of Weight-Loss — But Viking Already Owns It

Weight loss lawsuits

Pfizer Inc's (NYSE:PFE) lawsuit. Novo Nordisk A/S' (NYSE:NVO) counterbid. And in the middle of it all — a quiet $45 million position that might turn into Andreas Halvorsen's next masterstroke. After years of fighting from the sidelines of the Ozempic boom, Pfizer is finally throwing punches.

Pfizer is suing obesity-drug developer Metsera Inc (NASDAQ:MTSR) to block a takeover by Novo Nordisk. The war between the two pharma giants is driving MTSR stock higher, Wednesday.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.